Vivaglobin Related Clinical Trials
Evaluation of Efficacy and Tolerability of Hizentra� [Recruiting]
Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory Conditions [Recruiting]
Pharmacokinetics, Safety, and Tolerability of Subcutaneous GAMUNEX-C in Pediatric Subjects With Primary Immunodeficiency [Completed]
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis [Recruiting]
Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study) [Completed]
Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study) [Completed]
Subcutaneous Immunoglobulin (Hizentra) in Patients With Dermatomyositis: A Proof of Concept Study [Recruiting]
Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study) [Completed]
Tolerability and Safety of Immune Globulin Subcutaneous Solution and rHuPH20 in Primary Immunodeficiency Diseases (PID) [Completed]
A Study of Purified Human Antibodies Administered Subcutaneously to Patients With Multifocal Motor Neuropathy (MMN) [Completed]
Subcutaneous Immunoglobulin for CIDP [Recruiting]
Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (EU Extension Study) [Completed]
Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy [Completed]
Immune Globulin Subcutaenous (Human), 20% [Completed]
Phase 2/3 Study of IGSC, 20% in PIDD [Completed]
Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy [Completed]
Retrospective Chart Review of Subcutaneous IgG Use in Infants [Completed]
Immunoglobulin Dosage and Administration Form in CIDP and MMN [Active, not recruiting]
Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis [Terminated]
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20) [Recruiting]
Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia [Enrolling by invitation]
Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID) [Completed]
|